Top Tweets for #phresearch
💜 Applications for the 2026 Pulmonary Hypertension Research Scholarships are now closed. Thank you to all applicants!
Stay tuned—we’ll announce the recipients soon!
#PHResearch #PHCommunity #PH #PHACanada
Registration is open for the PH Research Symposium! Explore the Navigating the Patient Journey | Women’s Health sessions, plus expert discussions on clinical trials and the future of PH care. 📅 Dec. 4 | Register: https://t.co/xxdnB7QA3Y #pulmonaryhypertension #phresearch
Encouraging news for the PH-ILD community. Pulmovant announced positive Phase 2 PHocus results for investigational therapy mosliciguat and has begun its Phase 3 PHrontier study.
Read more: https://t.co/qx6VAvFNYM
#PHenomenalHope #PHResearch
Grateful to our #Pulmonology and #RespiratoryHealth community for the meaningful exchanges at #PFFSummit2025. Together, we advance understanding in #PulmonaryHypertension and #InterstitialLungDisease, moving science and care forward. Together #WeBreatheUnited. #PHResearch #Lung
Our #MedicalAffairs team is grateful for the time with #Pulmonology colleagues at #PHPN2025. Insightful discussions on screening, practical considerations of therapy, multidisciplinary care, and new clinical developments—all advancing evidence to support care. #PHResearch
🚨 Published in the world’s #1 Biochem & Mol Bio journal!
Our PH review is out in Signal Transduction & Targeted Therapy (IF: 52.7)!
📌 20+ pathways
📌 Gene & cell therapy
📌 Cell–cell interactions decoded
🔗 https://t.co/XBAu1leCfw
#PHResearch #CardioTwitter #STTT
🎥 Missed #DDDS2025 in Amsterdam?
Catch Luke Howard’s talk: How Sotatercept will change the treatment algorithm 💊
▶️ Full recording: https://t.co/LxriIZ3TNO
@HelpMyBreathing
#PHResearch #DrugDevelopment #Sotatercept #PVRI
We’re thrilled to be at #ATS2025! Grateful for the chance to share our team’s work and connect with the global pulmonary community. Here’s a quick look at some of the incredible science from Day 1 by our PH team—more to come!
#pulmonaryhypertension #PHresearch #TeamPH
@ATS_PC
Lower levels of ApoA-I, a component of HDL, was a significant predictor of mortality in pulmonary arterial hypertension patients in a study.
https://t.co/z4PKuDlM6y
#pulmonaryhypertension #phnews #phresearch
Clinical locations are expected to open by the end of the year in North America, Latin America, Europe, and the Asia Pacific region. https://t.co/o6haYzwDK5
#pulmonaryhypertension #phnews #phresearch
Top-line results from the Phase 2b portion of the study are expected in June 2024, according to AV-101’s developer, Aerovate Therapeutics. https://t.co/4ZPhOPqkvI
#pulmonaryhypertension #phnews #phresearch #clinicaltrial
Improvements in clinical measures like distance walked during the six-minute walk test were typically maintained out to a year. https://t.co/tKPrRqrtyr
#pulmonaryhypertension #phnews #phresearch #phtreatment
Here's a recap of the news and columns we featured this week. Head to our website to read them all: https://t.co/mTUQcTAPTp
#pulmonaryhypertension #phnews #phresearch #pulmonaryhypertensionawareness #livingwithph #phcommunity
A prediction model estimated that add-on sotatercept will prolong survival by threefold for pulmonary arterial hypertension (PAH) patients. https://t.co/vOBJHKOK0R
#pulmonaryarterialhypertension #phnews #phresearch
After about 1.3 years of treatment, 61.8% achieved or maintained low-risk status compared to 38.2% at baseline. See more: https://t.co/0MgMvF8vhx
#pulmonaryarterialhypertension #phnews #phresearch
Real-world study results show nearly 25% of patients experienced a reduction in symptom severity after 1.5 years of follow-up. https://t.co/ELHWqLzoNM
#pulmonaryarterialhypertension #phnews #phresearch
The vasoreactivity test is typically given only to people with PAH, and usually not to those with Group 2 PH. https://t.co/AuAhmxt70g
#pulmonaryhypertension #phnews #phresearch
Here's a recap of the news and columns we featured this week. Head to our website to read them all: https://t.co/mTUQcTAPTp
#pulmonaryhypertension #phnews #phresearch #pulmonaryhypertensionawareness #livingwithph #phcommunity
The ARRDC3 gene may be a biomarker for iron-related cell death in CTEPH and a potential treatment target, according to a new study. https://t.co/PxhDd9f5wL
#pulmonaryhypertension #phnews #phresearch #CTEPH
Nearly 35% of patients were deemed high risk when beginning therapy. After about 1.3 years, no patients were considered high risk. https://t.co/o0nrAbOCvp
#pulmonaryhypertension #phnews #phresearch #phtreatment
Last Seen Hashtags on Sotwe
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.9M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.2M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers